Smile Invest completed the acquisition of majority stake in IGS GeboJagema from Nordian Capital.

Smile Invest, an investment firm, completed the acquisition of majority stake in IGS GeboJagema, a high-end, multi-cavity injection moulds manufacturer, developer and validator, from Nordian Capital. Financial terms were not disclosed. "This transition comes at the right moment. We are currently working on our entry into the United States, where there are a lot of possibilities for our products which are tailored to the medical sector. The medical sector has a zero tolerance towards risk. We offer high quality, high precision moulds and together with validation services provide a one stop solution. The partnership with Smile Invest offers new possibilities to us driven by their technological knowledge, international experience and network," Peter Mertens, IGS GeboJagema CEO.